Respiratory infections: Pneumonia, lung abscess, and empyema

Seminars in Pediatric Surgery

Volumn 17, Issue 1, 2008, Pages 42-52

  Puligandla, Pramod S ^a   Laberge, Jean Martin ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Empyema; Immunocompromised patients; Lung abscess; Opportunistic lung infection; Pneumonia in children

Indexed keywords

ARTICLE; BACTERIAL INFECTION; BRONCHIOLITIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; EMPYEMA; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; HUMAN METAPNEUMOVIRUS; IMMUNOCOMPROMISED PATIENT; LUNG ABSCESS; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA PNEUMONIAE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VIRUS INFECTION;

CHILD; EMPYEMA, PLEURAL; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LUNG ABSCESS; NEOPLASMS; PNEUMONIA;

EID: 37349076208     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2007.10.007     Document Type: Article

References (80)

1. Bhutta Z.A. Dealing with childhood pneumonia in developing countries: how can we make a difference?. Arch Dis Child 92 (2007) 286-288
2. Wardlaw T., Salama P., Johansson E.W., et al. Pneumonia: the leading killer of children. Lancet 368 (2006) 1048-1050
3. Colin A.A. Pneumonia in the developed world. Paediatr Respir Rev 7 suppl 1 (2006) S138-S140
4. Tan T.Q., Mason Jr. E.O., Wald E.R., et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110 (2002) 1-6
5. English M. Impact of bacterial pneumonias on world child health. Paediatr Respir Rev 1 (2000) 21-25
6. Hale K.A., and Isaacs D. Antibiotics in childhood pneumonia. Paediatr Respir Rev 7 (2006) 145-151
7. Chiou C.C., and Yu V.L. Severe pneumococcal pneumonia: new strategies for management. Curr Opin Crit Care 12 (2006) 470-476
8. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 346 (2002) 429-437
9. Murray D.L., and Gilsdorf J.R. Chemoprophylaxis for household contacts of index cases of invasive non-type b Haemophilus influenzae disease. Pediatr Infect Dis J 20 (2001) 1099-1100
10. Correa A.G., and Starke J.R. Bacterial pneumonias. In: Chernick V., and Boat T.F. (Eds). Kendig's Disorders of the Respiratory Tract in Children (1998), W.B. Saunders Company, Philadelphia, PA
11. Laberge J.M., Puligandla P., and Flageole H. Asymptomatic congenital lung malformations. Semin Pediatr Surg 14 (2005) 16-33
12. Nelson C.T. Mycoplasma and Chlamydia pneumonia in pediatrics. Semin Respir Infect 17 (2002) 10-14
13. Gaydos C.A., Roblin P.M., Hammerschlag M.R., et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 32 (1994) 903-905
14. Corsaro D., Valassina M., Venditti D., et al. Multiplex PCR for rapid and differential diagnosis of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory infections. Diagn Microbiol Infect Dis 35 (1999) 105-108
15. Donald P.R. Childhood tuberculosis. Curr Opin Pulm Med 6 (2000) 187-192
16. Donald P.R. Preventing tuberculosis in childhood. Indian J Pediatr 67 (2000) 383-385
17. Taylor Z., Nolan C.M., and Blumberg H.M. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 54 (2005) 1-81
18. Inselman M.D., and Kendig E.L. Tuberculosis. In: Chernick V., and Boat T.F. (Eds). Kendig's Disorders of the Respiratory Tract in Children (1998), W.B. Saunders Company, Philadelphia, PA
19. Lodha R., and Kabra S.K. Newer diagnostic modalities for tuberculosis. Indian J Pediatr 71 (2004) 221-227
20. Enarson D.A. Use of the tuberculin skin test in children. Paediatr Respir Rev 5 suppl A (2004) S135-S137
21. Hewitson J.P., and Von Oppell U.O. Role of thoracic surgery for childhood tuberculosis. World J Surg 21 (1997) 468-474
22. Freixinet J. Surgical indications for treatment of pulmonary tuberculosis. World J Surg 21 (1997) 475-479
23. Jones D., and Havlir D.V. Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med 23 (2002) 665-674
24. Griffith D.E. Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis. Am J Respir Crit Care Med 167 (2003) 810-812
25. Han D., Lee K.S., Koh W.J., et al. Radiographic and CT findings of nontuberculous mycobacterial pulmonary infection caused by Mycobacterium abscessus. AJR Am J Roentgenol 181 (2003) 513-517
26. Brown-Elliott B.A., Griffith D.E., and Wallace Jr. R.J. Diagnosis of nontuberculous mycobacterial infections. Clin Lab Med 22 (2002) 911-925
27. Puligandla P.S., and Laberge J.M. Infections and diseases of the lungs, pleura, and mediastinum. In: Grosfeld J.L., O'Neill J.A., Coran AG A.G., et al. (Eds). Pediatric Surgery (2006), Mosby, Philadelphia, PA
28. Smyth R.L., and Openshaw P.J. Bronchiolitis. Lancet 368 (2006) 312-322
29. Lowther S.A., Shay D.K., Holman R.C., et al. Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children. Pediatr Infect Dis J 19 (2000) 11-17
30. Bordley W.C., Viswanathan M., King V.J., et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med 158 (2004) 119-126
31. Kellner J.D., Ohlsson A., Gadomski A.M., et al. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev (2000) CD001266
32. Hartling L., Wiebe N., Russell K., et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev (2004) CD003123
33. Patel H., Platt R., Lozano J.M., et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (2004) CD004878
34. Davison C., Ventre K.M., Luchetti M., et al. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med 5 (2004) 482-489
35. Kamal-Bahl S., Doshi J., and Campbell J. Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review. Arch Pediatr Adolesc Med 156 (2002) 1034-1041
36. Hamelin M.E., and Boivin G. Human metapneumovirus: a ubiquitous and long-standing respiratory pathogen. Pediatr Infect Dis J 24 (2005) S203-S207
37. van den Hoogen B.G., de Jong J.C., Groen J., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7 (2001) 719-724
38. Boivin G., De S.G., Cote S., et al. Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 9 (2003) 634-640
39. Semple M.G., Cowell A., Dove W., et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 191 (2005) 382-386
40. Cote S., Abed Y., and Boivin G. Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol 41 (2003) 3631-3635
41. Kahn J.S. Epidemiology of human metapneumovirus. Clin Microbiol Rev 19 (2006) 546-557
42. Neville K., Renbarger J., and Dreyer Z. Pneumonia in the immunocompromised pediatric cancer patient. Semin Respir Infect 17 (2002) 21-32
43. Waite S., Jeudy J., and White C.S. Acute lung infections in normal and immunocompromised hosts. Radiol Clin North Am 44 (2006) 295-315
44. Vento S., and Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol 4 (2003) 595-604
45. Pizzo P.A., Rubin M., Freifeld A., et al. The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr 119 (1991) 679-694
46. Lehrnbecher T., Groll A.H., and Chanock S.J. Treatment of fungal infections in neutropenic children. Curr Opin Pediatr 11 (1999) 47-55
47. Collin B.A., and Ramphal R. Pneumonia in the compromised host including cancer patients and transplant patients. Infect Dis Clin North Am 12 (1998) 781-805
48. Aisner J., Schimpff S.C., Bennett J.E., et al. Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. J Am Med Assoc 235 (1976) 411-412
49. Bergen G.A., and Shelhamer J.H. Pulmonary infiltrates in the cancer patient. New approaches to an old problem. Infect Dis Clin North Am 10 (1996) 297-325
50. Choi Y.H., and Leung A.N. Radiologic findings: pulmonary infections after bone marrow transplantation. J Thorac Imaging 14 (1999) 201-206
51. Pizzo P.A., and Walsh T.J. Fungal infections in the pediatric cancer patient. Semin Oncol 17 (1990) 6-9
52. Heurlin N., Bergstrom S.E., Winiarski J., et al. Fungal pneumonia: the predominant lung infection causing death in children undergoing bone marrow transplantation. Acta Paediatr 85 (1996) 168-172
53. Blyth C.C., Palasanthiran P., and O'Brien T.A. Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics 119 (2007) 772-784
54. Meyers J.D., McGuffin R.W., Bryson Y.J., et al. Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 146 (1982) 80-84
55. van der Meer J.T., Drew W.L., Bowden R.A., et al. Summary of the International Consensus Symposium on Advances in the Diagnosis. Treatment and Prophylaxis and Cytomegalovirus Infection. Antiviral Res 32 (1996) 119-140
56. Pizzo P.A. Infectious complications in the child with cancer. II. Management of specific infectious organisms. J Pediatr 98 (1981) 513-523
57. Hughes W.T. Pneumocystis carinii pneumonitis. N Engl J Med 317 (1987) 1021-1023
58. Perez M.S., and Van Dyke R.B. Pulmonary infections in children with HIV infection. Semin Respir Infect 17 (2002) 33-46
59. Graham S.M. Impact of HIV on childhood respiratory illness: differences between developing and developed countries. Pediatr Pulmonol 36 (2003) 462-468
60. The CASCADE Collaboration. Survival after introduction of HAART in people with known duration of HIV-1 infection. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 355 (2000) 1158-1159
61. Mofenson L.M., Yogev R., Korelitz J., et al. Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Pediatr Infect Dis J 17 (1998) 872-880
62. Simonds R.J., and Orejas G. Pneumocystis carinii pneumonia and toxoplasmosis. In: Pizzo P.A., and Wilfert C. (Eds). Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents (1998), Williams & Wilkins, Baltimore, MD
63. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention. MMWR Recomm Rep 44 (1995) 1-11
64. Schneider M.M., Borleffs J.C., Stolk R.P., et al. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. Lancet 353 (1999) 201-203
65. Sanchez J.M., Ramos Amador J.T., Fernandez de M.S., et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 22 (2003) 863-867
66. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 45 (1996) 1-18
67. Prendergast A., Tudor-Williams G., Jeena P., et al. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet 370 (2007) 68-80
68. Antiretroviral therapy and medical management of pediatric HIV infection and 1997 USPHS/IDSA report on the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Pediatrics 102 (1998) 999-1085
69. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR Recomm Rep 48 (1999) 1-6
70. Whitley R.J., Jacobson M.A., Friedberg D.N., et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 158 (1998) 957-969
71. Shenep J.L., and Flynn P.M. Pulmonary fungal infections in immunocompromised children. Curr Opin Pediatr 9 (1997) 213-218
72. Patradoon-Ho P., and Fitzgerald D.A. Lung abscess in children. Paediatr Respir Rev 8 (2007) 77-84
73. Tan T.Q., Seilheimer D.K., and Kaplan S.L. Pediatric lung abscess: clinical management and outcome. Pediatr Infect Dis J 14 (1995) 51-55
74. Hoffer F.A., Bloom D.A., Colin A.A., et al. Lung abscess versus necrotizing pneumonia: implications for interventional therapy. Pediatr Radiol 29 (1999) 87-91
75. Yen C.C., Tang R.B., Chen S.J., et al. Pediatric lung abscess: a retrospective review of 23 cases. J Microbiol Immunol Infect 37 (2004) 45-49
76. Avansino J.R., Goldman B., Sawin R.S., et al. Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis. Pediatrics 115 (2005) 1652-1659
77. Sonnappa S., and Jaffe A. Treatment approaches for empyema in children. Paediatr Respir Rev 8 (2007) 164-170
78. Sonnappa S., Cohen G., Owens C.M., et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 174 (2006) 221-227
79. Finck C., Wagner C., Jackson R., et al. Empyema: development of a critical pathway. Semin Pediatr Surg 11 (2002) 25-28
80. Fuller M.K., and Helmrath M.A. Thoracic empyema, application of video-assisted thoracic surgery and its current management. Curr Opin Pediatr 19 (2007) 328-332